Are restricted mean survival time methods especially useful for noninferiority trials?
Author:
Affiliation:
1. Biometric Research Program, National Cancer Institute, Bethesda, MD, USA
2. Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Abstract
Publisher
SAGE Publications
Subject
Pharmacology,General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/1740774520976576
Reference31 articles.
1. The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with mice
2. Weighted Kaplan-Meier Statistics: A Class of Distance Tests for Censored Survival Data
3. Use of Irwin's restricted mean as an index for comparing survival in different treatment groups—Interpretation and power considerations
4. Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
5. Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nonconcurrent Controls in Platform Trials: Can We Borrow Their Concurrent Observation Data?;Statistics in Biopharmaceutical Research;2023-10-05
2. A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials;Clinical Trials;2023-06-20
3. Conversion of non-inferiority margin from hazard ratio to restricted mean survival time difference using data from multiple historical trials;Statistical Methods in Medical Research;2022-05-31
4. Non‐inferiority and clinical superiority of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes;Diabetes, Obesity and Metabolism;2022-05-29
5. Pitfall in the Design and Analysis of Comparative Oncology Trials With a Time-to-Event Endpoint and Recommendations;JNCI Cancer Spectrum;2022-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3